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With growing ketamine abuse, ketamine-induced uropathy (KIU) has become a vital health issue in
recent years. Although the lower urinary tract is the primary affected site, involvement of the upper
urinary tract is common, and KIU may progress rapidly. The main objective of a baseline imaging study is
evaluating the extent and complications of KIU after excluding other causes of uropathy. A compre-
hensive strategy for KIU evaluation through imaging is essential for effectively managing complications
and preventing further renal function deterioration. In this study, we describe the imaging presentation
of KIU and examine the role of various imaging modalities, such as ultrasound, intravenous urography,
and computed tomography, in diagnosing patients with KIU.
Copyright © 2015, Taiwan Urological Association. Published by Elsevier Taiwan LLC. This is an open access
article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).1. Introduction
Ketamine, a rapid-onset and short-acting anesthetic intro-
duced in the 1960s,1 has become a recreational drug during the
past 10e20 years because of its dissociative effect and addiction-
inducing properties.2 Ketamine abuse is prevalent in Taiwanese
nightclubs and has become the leading cause of substance abuse
in Taiwan since 2006.3 Street ketamine abuse may lead to serious
urological conditions and impose a substantial burden on health
care resources. Ketamine-associated ulcerative cystitis was ﬁrst
reported in 2007 by Shahani et al,4 when a patient presented
with lower urinary tract symptoms, namely severe dysuria, fre-
quency, urgency, and gross hematuria. Thereafter, ketamine-
induced uropathy (KIU) has been extensively reported in the
literature.5
The effect of ketamine on the urinary bladder is well estab-
lished. Studies have postulated that high concentrations of keta-
mine and its metabolites in urine might have a direct toxic effect on
urothelial cells, causing microvascular changes and neurogenic
inﬂammation or evoking autoimmune responses.2,6 Histopatho-
logical ﬁndings in experimental mice treated with ketaminey, Taipei Veterans General
iwan.
).
ociation. Published by Elsevier Tarevealed a loss of muscular proportion in the bladder wall accom-
panied with increased ﬁbrosis, principally in the lamina propria
and the muscular layer, which is clinically correlated with a con-
tracted urinary bladder.7 Bladder biopsies of patients with KIU
typically exhibit ulceration, inﬂammatory cell inﬁltration (pre-
dominantly eosinophils), and a varying degree of ﬁbrosis.4,5,8
Cystoscopic examination and biopsy (predominantly eosinophilic
inﬁltration) both suggest eosinophilic cystitis, but the absence of
documented peripheral eosinophilia and eosinophilic sediment
excludes this diagnosis.5 Whether KIU represents a new type of
eosinophilic cystitis is currently unclear.
KIU diagnosis is primarily established by the clinical presenta-
tion of severe lower urinary tract symptoms and a history of ke-
tamine abuse. The typical presentation symptoms include severe
urgency, urinary frequency, intermittent hematuria, nocturia,
dysuria, and bladder pain.3e5,9e11 Lower urinary tract examination,
including urodynamic and cystoscopic examination, are recom-
mended for these patients. Low bladder capacity and detrusor
muscle overactivity are the usual ﬁndings of urodynamic exami-
nations in patients with KIU.8 Rigid cystoscopy is an important
diagnostic tool in examining patients with KIU for excluding other
hematuria causes and evaluating interstitial cystitis severity
through visual inspection and biopsy.5,10 Cystoscopy ﬁndings
typically include a contracted bladder with reduced capacity, as
well as severe inﬂammation and epithelial denudation, which are
indicators of ulcerative cystitis.5 However, cystoscopy has limita-
tions. It is invasive, painful, and usually requires general anesthesia.iwan LLC. This is an open access article under the CC BY-NC-ND license (http://
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rule out upper urinary tract involvement.
Although the lower urinary tract is the primary site affected in
patients with KIU, the upper urinary tract can be equally
involved.2,9 Ketamine metabolites can be detected in the gelatinous
debris aspirated from the pelvicalyceal systems and the ureter.12 A
study of ketamine addiction in mice revealed foci of mononuclear
cell inﬁltration around the glomeruli and the blood vessels within
the kidney and ureter, suggesting that ketamine induces chronic
interstitial inﬂammation.13 KIU incidence involving the upper uri-
nary tract varies widely in literature and ranges from 13% to 51%.2,9
Factors contributing to disease extent, such as dosage and fre-
quency of ketamine abuse, and symptom severity are currently
unavailable. Furthermore, a previous study reported no signiﬁcantFig. 1. CTU study of a 24-year-old woman with a 2-year history of ketamine abuse. (A) Sequ
CTU study. The axial images of the combined nephrographic and excretory phase reveal blad
hydroureter. (CeE) Three-phase CTU exam after 6 months [(C) nephrographic phase, (D) excr
strong mucosal enhancement of renal pelvis and ureters (C, E), hydronephrosis, and hydr
ketamine-induced uropathy. CTU ¼ computed tomography urography.correlation between interstitial cystitis severity and the upper
urinary tract involvement in KIU.14
KIU may progress rapidly, therefore, close monitoring and im-
aging modalities are necessary for analyzing renal function
(Fig. 1).14 Because low bladder capacity is the major complication of
KIU, augmentation cystoplasty is usually suggested for symptom
relief. However, if the patient continues ketamine abuse, the dis-
ease further progresses to the upper urinary tract. In such cases,
augmentation cystoplasty cannot beneﬁt the patient. In a study by
Ng et al,15 four patients with KIU were treated for ketamine-related
bladder contractures using augmentation cystoplasty. All four pa-
tients resumed ketamine consumption after surgery. The mean
maximal baseline and postoperative bladder capacity were 37.5 cc
(range, 25e50 cc) and up to 400e500 cc, respectively. However,ential axial post-contrast images and (B) coronal reconstruction image of a split-bolus
der wall thickening (arrows) and a small bladder volume. There is no hydronephrosis or
etory phase, and (E) coronal reconstruction of nephrogenic phase] demonstrates diffuse
oureter, indicating rapid disease progression and upper urinary tract involvement by
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which was secondary to new-onset ureteral strictures in two pa-
tients and to sepsis in one patient. Therefore, simple surgical
management of the physical component of the contracted bladder
without a complete evaluation of disease extent and ceasing ke-
tamine use after surgery may only temporarily relieve symptoms
and cause further complications in some patients.
KIU is an emerging medical condition requiring a multidisci-
plinary approach to treating patients. Imaging modalities are
noninvasive and ﬁrst-line methods in KIU diagnosis. The main
objective of baseline imaging is evaluating the extent and compli-
cations of KIU and excluding other causes of uropathy.6,14 Imaging
modalities are also used in evaluating KIU progression at follow-up.
Ultrasound, intravenous urography (IVU), and computed tomog-
raphy (CT) are vital imaging modalities for evaluating the
morphology of the renal collecting system. Diuretic renography is a
nuclear-medicine method for evaluating renal function and the
severity of obstructive uropathy and differentiating between
obstructive and nonobstructive causes of hydronephrosis or
hydroureter. Diuretic renography could be an efﬁcient tool for
follow-up. In the following paragraphs, we introduce the ﬁndings
and roles of various noninvasive imaging modalities in diagnosing
KIU with a focus on ultrasound, IVU, and CT.
2. Ultrasound
2.1. Ultrasound: urinary bladder
Ultrasound should be used as the primary imaging tool for
examining the urinary system in patients with KIU because it is a
real-time, radiation-free, portable, and less-expensive method as
compared with CT and magnetic resonance imaging. Major ultra-
sound ﬁndings in patients with KIU are low bladder capacity with
bladder wall thickening and sometimes calciﬁcation. Blood clots
may be observed in patients with hematuria. Bladder distention is
recommended for accurate measurement of bladder wall thickness
and volume. However, distention is usually painful for patients and
can lead to detrusor muscle overactivity. In a study byMason et al,9
67% of patients with ketamine-induced cystitis exhibited bladder
wall thickening and low bladder volume. However, one-third (4 out
of 12) of the patients were unable to ﬁll their bladders for the ex-
amination because of extreme discomfort, and the examination
was halted so that the patients could empty their bladder. There-
fore, KIU diagnosis through bladder wall thickness measurement is
highly controversial. Another way tomeasure bladder capacity is by
adding the voided volume and the residual urine volume. Accord-
ing to the report by Tam et al,16 patients were asked to drink as
much as they could tolerate and instructed to void in the uro-
ﬂowmeter when they had a strong desire to void. The urology nurse
performed the ultrasound bladder scan to estimate the residual
urine volume in the bladder immediately after the uroﬂowmetry
test. Bladder emptying efﬁciency could be estimated by dividing
the voided volume by the bladder capacity and expressing as a
percentage. Since ineffective bladder emptying is another feature of
KIU, both bladder capacity and voiding efﬁciency could be obtained
by this method and, thus, could be used to evaluate the progress of,
and response to, treatment for these patients.
2.2. Ultrasound: kidneys
Examining bilateral kidneys is an essential part of ultrasound
exams for patients with KIU. An advantage of ultrasound is its
ability to detect hydronephrosis. Huang et al14 reported that 44.4%
of patients with KIU exhibited hydronephrosis, which is consistent
with the ﬁndings of Chu et al2 (51%). Hydronephrosis in patientswith KIU may be secondary to low bladder capacity, vesicle-
ureteral reﬂux (VUR), KIU involvement in the upper urinary tract,
or other causes of obstructive uropathy, such as stones or tumors.
Treatment efﬁciency can only be determined when the cause of
hydronephrosis and extent of involvement are accurately delin-
eated. Voiding cystourethrography should be arranged to evaluate
the possibility of VUR. If obstructive uropathy is observed, urine
diversion through ureteral stenting or nephrostomy is necessary for
relieving obstructions and early renal function preservation. In a
study by Tam et al16, renal impairment was higher in patients with
hydronephrosis (4 of 13, 30.8%) than in those without hydro-
nephrosis (6 of 147, 4.1%; p ¼ 0.004).
The limitation of ultrasound is that the ureters are usually
obscured on scans by bowel gas and pelvic bony structures. Ureteral
thickening and luminal narrowing, which are presentations of
upper urinary tract involvement, cannot be directly detected
through ultrasound. Therefore, when upper urinary tract involve-
ment is suspected, IVU and CT should be performed.
3. IVU
The entire upper and lower urinary tract can be imaged using
IVU. Bilateral renal function canbe comparedand evaluated through
sequential ﬁlming after intravenous contrast administration. When
the upper urinary tract is involved in KIU, hydronephrosis and
hydroureter is observed, along with luminal narrowing of the
involved segment. However, IVU has some limitations. First, in cases
of severe obstruction or renal function impairment, the level and
cause of obstruction cannot be imaged. Second, hydronephrosis can
be caused by long-term decrease in bladder compliance, VUR, KIU
involvement in the ureterovesical junction, KIU involvement in the
ureter, or other causes of obstructive uropathy. When the obstruc-
tion is at the ureterovesical junction, the root cause of hydro-
nephrosis cannot be determined and distinguished from the various
causes. In a study by Chu et al2, most patients with KIU had bilateral
hydronephrosis and hydroureters at the ureterovesical junctions on
IVU study. Third, IVU is time consuming, which may cause uneasi-
ness in patients with lower urinary tract symptoms.9
4. CT
4.1. CT techniques
Of the various imaging tools, CT urography (CTU) is the most
useful because it allows simultaneous visualization of both the
upper and lower urinary tracts and the ureters can be directly
observed.5,9,14 CTU is widely used in examining patients with uri-
nary tract symptoms, particularly in hematuria diagnosis. Conven-
tionally, the three-phase CTU comprises the noncontrast phase, the
nephrographic phase, inwhich the scan is obtained 90 seconds after
intravenous administration of the contrast medium, and the
excretory phase, in which the scan is obtained at least 5 minutes
after injecting the contrast medium.17,18 Coronal multiplanar refor-
mation images can be generated using a multislice volumetric
dataset of both phases. In patients with KIU, mucosal enhancement
and wall thickening can be observed clearly in the nephrographic
phase, whereas the lumen of the urinary tract, particularly the
ureter, can be observed clearly in the excretory phase (Fig. 1). The
extent of upper urinary tract involvement can thus be determined.
Excretory phase is essential for detecting congenital anomaly of the
collecting system, such as duplication (Fig. 2).
Split-bolus CTU has been introduced after recent concerns
regarding radiation dosage. In split-bolus CTU, 30 mL of contrast
medium is administered after acquiring an unenhanced scan from
the kidney to the bladder. During the interval, the patient is
Fig. 2. A 26-year-old woman with a 2-year history of ketamine abuse, observed to have hydronephrosis and suspected to have ureteral involvement of KIU. (A) IVU study (left, 15-
minute ﬁlm; right, 30-minute ﬁlm) reveals duplication of the right kidney. Only the collecting system of the upper moiety is opaciﬁed. The lower moiety of the right and left kidneys
shows delayed function and hydronephrosis, while the obstruction level and cause could not be decided. (B, C) The coronal reformation images of three-phase CTU exam [(B)
nephrographic phase and (C) excretory phase] reveals diffuse thickening of the wall of the lower moiety of the right collecting system (arrows in B) and dilatation, indicating KIU
involvement. In excretory phase, the uninvolved upper moiety is opaciﬁed (open arrow in C). Note the unsymmetrical renal function of the upper and lower moiety of the right
kidney. CTU ¼ computed tomography urography; IVU ¼ intravenous urography; KIU ¼ ketamine-induced uropathy.
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the patient is prepared for another scan; 70 mL of contrast medium
is administered and the second scan is performed for the same scan
range after a 90-second interval. Coronal multiplanar reformation
images can be generated using a multislice volumetric dataset of
both phases. By administrating two separate boluses of contrast
medium before the scan, tissue perfusion information and luminal
contrast can be obtained in a single scan. The radiation dose can be
effectively reduced without compromising lesion detection in the
urinary tract.18e22 Split-bolus CTU has been adapted as a standard
protocol in numerous institutions and is particularly recommended
for young patients.
The major concern regarding the use of split-bolus CTU in
examining patients with KIU is that the mucosal enhancement isobscured by the intraluminal contrast medium. In our previous
study, the segment of mucosal enhancement is observed in the
nephrographic phase, and wall thickening and dilatation of the
proximal ureter are invariably observed in the corresponding
segment in the excretory phase.12 Therefore, the absence of infor-
mation regarding mucosal enhancement does not interfere with
the ability of split-bolus CTU to determine the extent of KIU-
induced inﬂammation.
4.2. CT features
Diffuse bladder wall thickening, low bladder volume, and peri-
vesical inﬁltration are predominant CT ﬁndings (Fig. 1). When
the ureter is involved, ureteral wall thickening, strong mucosal
S.-H. Shen, J.-H. Wang / Urological Science 26 (2015) 160e164164enhancement, and dilatation of the involved and proximal urinary
tract can be observed (Figs. 1 and 2). Furthermore, hydronephrosis
in patients with KIU may be caused by long-term decrease in
bladder compliance, VUR, KIU involvement in ureterovesicle junc-
tion, or KIU involvement in the ureter. The advantage of CT is that it
demonstrates the level of ureteral involvement and excludes other
causes of obstruction, such as tumors or stones. The presence of
contrast medium in the vagina is not uncommon and is possibly
caused by urine leakage during the examination and subsequent
reﬂux to the vagina. The possibility of vesico-vaginal ﬁstula should
be ruled out after careful clinical history correlation and cystoscopic
examination.
Radiation dose is the major concern in performing CT scans in
patients with a history of ketamine abuse, as the patients are
usually young. As KIU progresses rapidly, the patients may need
close follow-up through imaging modalities. Alternatively, IVU and
CT may be more favorable than other tests for adequate follow-up
of these patients.
5. Conclusion
With growing and widespread recreational ketamine use, KIU
has become a prevalent health issue in our society. The main
objective of a baseline imaging study is evaluating the extent and
complications of KIU and excluding other causes for uropathy.
Adequate baseline imaging evaluation of KIU is key in effectively
managing complications and preventing further renal function
deterioration. An integrated multidisciplinary approach involving
radiology, urology, psychiatry, and social services is crucial in
treating these patients.
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